{"id":550,"date":"2021-12-05T14:43:25","date_gmt":"2021-12-05T19:43:25","guid":{"rendered":"https:\/\/opentextbc.ca\/nursingpharmacology\/chapter\/concept-map-cognition\/"},"modified":"2023-03-03T11:38:51","modified_gmt":"2023-03-03T16:38:51","slug":"concept-map-cognition","status":"publish","type":"chapter","link":"https:\/\/opentextbc.ca\/nursingpharmacology\/chapter\/concept-map-cognition\/","title":{"raw":"Concept Map: Mood and Affect","rendered":"Concept Map: Mood and Affect"},"content":{"raw":"<img class=\"alignnone wp-image-549 size-full\" src=\"https:\/\/opentextbc.ca\/accessibilitytoolkit\/wp-content\/uploads\/sites\/397\/2021\/12\/Screen-Shot-2022-03-31-at-1.44.24-PM.png\" alt=\"concept map for mood and affect\" width=\"1153\" height=\"657\" \/>\r\n<h1>Image Description<\/h1>\r\n<strong>Mood and affect concept map description:<\/strong> This is a concept map that shows the components of mood and affect. It starts with the definition: the way a person feels and acts. And then continues with the components of mood and affect:\r\n\r\nScope\r\n<ul>\r\n \t<li>Mood Spectrum<\/li>\r\n \t<li class=\"O1\">Severe Mania<\/li>\r\n \t<li class=\"O1\">Hypomania<\/li>\r\n \t<li class=\"O1\">Euthymia<\/li>\r\n \t<li class=\"O1\">Melancholy<\/li>\r\n \t<li class=\"O1\">Severe Melancholy<\/li>\r\n<\/ul>\r\nAssessment\r\n<ul>\r\n \t<li>agitation, sadness, speech<\/li>\r\n \t<li>energy, cognition, functional impairment<\/li>\r\n \t<li>mental status assessment<\/li>\r\n \t<li>suicidal ideation<\/li>\r\n \t<li>must monitor for adverse effects of medication treatment such as serotonin symptoms suicidal ideation<\/li>\r\n<\/ul>\r\nManagement\r\n<ul>\r\n \t<li>improvement of social determinants of health<\/li>\r\n \t<li>mental status exam and screening instruments<\/li>\r\n \t<li>psychotherapy pharmacotherapy (antidepressants, anti-mania, antipsychotics, CNS depressants)<\/li>\r\n<\/ul>\r\nConsequences\r\n<ul>\r\n \t<li>High use of medical care<\/li>\r\n \t<li>Potential for suicide<\/li>\r\n \t<li>Social and relational impacts<\/li>\r\n \t<li>Cognitive impacts<\/li>\r\n<\/ul>\r\nPhysiological Process\r\n<ul>\r\n \t<li class=\"O0\">Cerebral Cortex\r\n<ul>\r\n \t<li class=\"O0\"><span style=\"font-size: 14pt;\">reduced blood flow and abnormal phosphorous metabolism (especially in the prefrontal cortex)<\/span><\/li>\r\n<\/ul>\r\n<\/li>\r\n \t<li class=\"O0\">Neurotransmitters\r\n<ul>\r\n \t<li class=\"O0\"><span style=\"font-size: 14pt;\">Dopamine<\/span><\/li>\r\n \t<li class=\"O0\"><span style=\"font-size: 14pt;\">Serotonin<\/span><\/li>\r\n \t<li class=\"O0\"><span style=\"font-size: 14pt;\">Norepinephrine<\/span><\/li>\r\n<\/ul>\r\n<\/li>\r\n<\/ul>","rendered":"<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-549 size-full\" src=\"https:\/\/opentextbc.ca\/accessibilitytoolkit\/wp-content\/uploads\/sites\/397\/2021\/12\/Screen-Shot-2022-03-31-at-1.44.24-PM.png\" alt=\"concept map for mood and affect\" width=\"1153\" height=\"657\" srcset=\"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/397\/2021\/12\/Screen-Shot-2022-03-31-at-1.44.24-PM.png 1153w, https:\/\/opentextbc.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/397\/2021\/12\/Screen-Shot-2022-03-31-at-1.44.24-PM-300x171.png 300w, https:\/\/opentextbc.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/397\/2021\/12\/Screen-Shot-2022-03-31-at-1.44.24-PM-1024x583.png 1024w, https:\/\/opentextbc.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/397\/2021\/12\/Screen-Shot-2022-03-31-at-1.44.24-PM-768x438.png 768w, https:\/\/opentextbc.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/397\/2021\/12\/Screen-Shot-2022-03-31-at-1.44.24-PM-65x37.png 65w, https:\/\/opentextbc.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/397\/2021\/12\/Screen-Shot-2022-03-31-at-1.44.24-PM-225x128.png 225w, https:\/\/opentextbc.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/397\/2021\/12\/Screen-Shot-2022-03-31-at-1.44.24-PM-350x199.png 350w\" sizes=\"auto, (max-width: 1153px) 100vw, 1153px\" \/><\/p>\n<h1>Image Description<\/h1>\n<p><strong>Mood and affect concept map description:<\/strong> This is a concept map that shows the components of mood and affect. It starts with the definition: the way a person feels and acts. And then continues with the components of mood and affect:<\/p>\n<p>Scope<\/p>\n<ul>\n<li>Mood Spectrum<\/li>\n<li class=\"O1\">Severe Mania<\/li>\n<li class=\"O1\">Hypomania<\/li>\n<li class=\"O1\">Euthymia<\/li>\n<li class=\"O1\">Melancholy<\/li>\n<li class=\"O1\">Severe Melancholy<\/li>\n<\/ul>\n<p>Assessment<\/p>\n<ul>\n<li>agitation, sadness, speech<\/li>\n<li>energy, cognition, functional impairment<\/li>\n<li>mental status assessment<\/li>\n<li>suicidal ideation<\/li>\n<li>must monitor for adverse effects of medication treatment such as serotonin symptoms suicidal ideation<\/li>\n<\/ul>\n<p>Management<\/p>\n<ul>\n<li>improvement of social determinants of health<\/li>\n<li>mental status exam and screening instruments<\/li>\n<li>psychotherapy pharmacotherapy (antidepressants, anti-mania, antipsychotics, CNS depressants)<\/li>\n<\/ul>\n<p>Consequences<\/p>\n<ul>\n<li>High use of medical care<\/li>\n<li>Potential for suicide<\/li>\n<li>Social and relational impacts<\/li>\n<li>Cognitive impacts<\/li>\n<\/ul>\n<p>Physiological Process<\/p>\n<ul>\n<li class=\"O0\">Cerebral Cortex\n<ul>\n<li class=\"O0\"><span style=\"font-size: 14pt;\">reduced blood flow and abnormal phosphorous metabolism (especially in the prefrontal cortex)<\/span><\/li>\n<\/ul>\n<\/li>\n<li class=\"O0\">Neurotransmitters\n<ul>\n<li class=\"O0\"><span style=\"font-size: 14pt;\">Dopamine<\/span><\/li>\n<li class=\"O0\"><span style=\"font-size: 14pt;\">Serotonin<\/span><\/li>\n<li class=\"O0\"><span style=\"font-size: 14pt;\">Norepinephrine<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n","protected":false},"author":90,"menu_order":7,"template":"","meta":{"pb_show_title":"on","pb_short_title":"","pb_subtitle":"","pb_authors":["amanda-egert","manu-gill","kimberly-lee"],"pb_section_license":""},"chapter-type":[],"contributor":[70,71,72],"license":[],"class_list":["post-550","chapter","type-chapter","status-publish","hentry","contributor-amanda-egert","contributor-kimberly-lee","contributor-manu-gill"],"part":527,"_links":{"self":[{"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/550","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters"}],"about":[{"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/wp\/v2\/types\/chapter"}],"author":[{"embeddable":true,"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/wp\/v2\/users\/90"}],"version-history":[{"count":2,"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/550\/revisions"}],"predecessor-version":[{"id":1568,"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/550\/revisions\/1568"}],"part":[{"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/parts\/527"}],"metadata":[{"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/550\/metadata\/"}],"wp:attachment":[{"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/wp\/v2\/media?parent=550"}],"wp:term":[{"taxonomy":"chapter-type","embeddable":true,"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapter-type?post=550"},{"taxonomy":"contributor","embeddable":true,"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/wp\/v2\/contributor?post=550"},{"taxonomy":"license","embeddable":true,"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/wp\/v2\/license?post=550"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}